TRAP220/MED1 Products

Description

MED1, also referred to as Mediator Complex Subunit 1, localizes to the nucleus and is involved in DNA repair. MED1 is able to remove Uracil in Uracil-Guanine mismatched base-pairs. Current research on MED1 is being performed in relation to several diseases and disorders including ovarian cancer, thyroiditis, breast cancer, Parkinson's disease, influenza, alopecia, Williams syndrome, diabetes mellitus, ataxia telangiectasia, thyroid cancer, Alzheimer's disease and rickets. MED1 has also been shown to have interactions with p53, MED15, RARA, KAT2A, and CDK8 in pathways such as fatty acid, triacylglycerol, and ketone body metabolism and the PPAR pathway.

Bioinformatics

Uniprot	Q15648 Human
Product By Gene ID	5469
Alternate Names	Activator-recruited cofactor 205 kDa component ARC205 CRSP1TRIP2 CRSP200p53 regulatory protein RB18A DRIP230PPAR-binding protein mediator complex subunit 1DRIP205 mediator of RNA polymerase II transcription subunit 1 PBPPPARGBP Peroxisome proliferator-activated receptor-binding protein PPAR binding protein PPARBPMGC71488 PPARG binding protein RB18ATR-interacting protein 2 Thyroid hormone receptor-associated protein complex 220 kDa component thyroid hormone receptor-associated protein complex component TRAP220 thyroid receptor interacting protein 2 Thyroid receptor-interacting protein 2 Trap220 TRAP220TRIP-2 vitamin D receptor-interacting protein 230 kD Vitamin D receptor-interacting protein complex component DRIP205

Research Areas for TRAP220/MED1

Find related products by research area and learn more about each of the different research areas below.

Cancer